Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lazzarin

Showing results (321-330 of 384) with videos related to

Pageof 39
Sort By:
HIV Medicine|September 22, 2012
Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapyN Gianotti, L Galli, B Bocchiola, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2000
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survivalA Mocroft, S Madge, A M Johnson, et al.
AIDS Research and Human Retroviruses|August 26, 1999
Anti-CD4 antibodies in exposed seronegative adults and in newborns of HIV type 1-seropositive mothers: a follow-up studyL Lopalco, Z Magnani, C Confetti, et al.
Blood|February 26, 2000
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonalityH Soudeyns, G Campi, G P Rizzardi, et al.
Journal of Acquired Immune Deficiency Syndromes|October 1, 1993
Autoantibodies against beta 2-microglobulin-free HLA antigens in AIDS patientsM O Borghi, C De Santis, W Barcellini, et al.
The New England Journal of Medicine|August 17, 1995
A controlled trial of zidovudine in primary human immunodeficiency virus infectionS Kinloch-De Loës, B J Hirschel, B Hoen, et al.
AIDS (London, England)|November 14, 1998
Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study GroupO Kirk, A Mocroft, T L Katzenstein, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1992
Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvementA Lazzarin, A Castagna, G Cavalli, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1985
Immunohistochemical reactivity of anti-LAV p18 monoclonal antibody in lymph nodes from PGL and AIDS patientsC L Parravicini, L Vago, G C Costanzi, et al.
Journal of Clinical Epidemiology|November 1, 1996
Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. The AIDS IN EUROPE Study GroupA N Phillips, A Lazzarin, J Gonzales-Lahoz, et al.
Pageof 39

Showing results (321-330 of 384) with videos related to

Sort By:
Pageof 39
HIV Medicine|September 22, 2012
Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapyN Gianotti, L Galli, B Bocchiola, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2000
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survivalA Mocroft, S Madge, A M Johnson, et al.
AIDS Research and Human Retroviruses|August 26, 1999
Anti-CD4 antibodies in exposed seronegative adults and in newborns of HIV type 1-seropositive mothers: a follow-up studyL Lopalco, Z Magnani, C Confetti, et al.
Blood|February 26, 2000
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonalityH Soudeyns, G Campi, G P Rizzardi, et al.
Journal of Acquired Immune Deficiency Syndromes|October 1, 1993
Autoantibodies against beta 2-microglobulin-free HLA antigens in AIDS patientsM O Borghi, C De Santis, W Barcellini, et al.
The New England Journal of Medicine|August 17, 1995
A controlled trial of zidovudine in primary human immunodeficiency virus infectionS Kinloch-De Loës, B J Hirschel, B Hoen, et al.
AIDS (London, England)|November 14, 1998
Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study GroupO Kirk, A Mocroft, T L Katzenstein, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1992
Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvementA Lazzarin, A Castagna, G Cavalli, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1985
Immunohistochemical reactivity of anti-LAV p18 monoclonal antibody in lymph nodes from PGL and AIDS patientsC L Parravicini, L Vago, G C Costanzi, et al.
Journal of Clinical Epidemiology|November 1, 1996
Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. The AIDS IN EUROPE Study GroupA N Phillips, A Lazzarin, J Gonzales-Lahoz, et al.
Pageof 39